Logo

Roche Gets European Marketing Clearance for New HIV-1 Molecular Assay

Dec 15, 2008
NEW YORK (GenomeWeb News) – Roche has received the CE-IVD Mark for its new dual-target HIV-1 test allowing it to be used for clinical use throughout the European Union, the firm said today.
 
The firm’s Cobas AmpliPrep/Cobas TaqMan HIV-1 Test, v2.0 simultaneously amplifies and detects two separate regions of the HIV-1genome, which Roche said enables reliable results even when mutations are present. The test also uses real-time PCR to quantify the amount of HIV-1RNA in a patient’s blood.
 
“Because it is impossible to predict when these mutations will occur, we have designed this test to detect all HIV-1 (Group M and O) strains," Daniel O’Day, president and CEO of Roche Molecular Diagnostics, said in a statement.
 
Roche noted that the test is the first dual-target test offered on the Cobas AmpliPrep/Cobas TaqMan System.
 

Breaking News
The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.